Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status

References

• Bak, T. H., Crawford, L. M., Hearn, V. C., Mathuranath, P. S., & Hodges, J. R. (2005). Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase, 11(4), 268–273.
   PubMed Web of Science ®Google Scholar
• Bang, J., Lobach, I. V., Lang, A. E., Grossman, M., Knopman, D. S., Miller, B. L., … Investigators, A. L. (2016). Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials. Parkinsonism Relat Disord, 28, 41–48.
   PubMed Web of Science ®Google Scholar
• Baune, B. T., Miller, R., McAfoose, J., Johnson, M., Quirk, F., & Mitchell, D. (2010, April 30). The role of cognitive impairment in general functioning in major depression. Psychiatry Res, 176(2–3), 183–189. PubMed PMID: 20138370.
   PubMed Web of Science ®Google Scholar
• Beatty, W. W., Ryder, K. A., Gontkovsky, S. T., Scott, J. G., McSwan, K. L., & Bharucha, K. J. (2003). Analyzing the subcortical dementia syndrome of Parkinson’s disease using the RBANS. Arch Clin Neuropsychol, 18(5), 509–520.
   PubMed Web of Science ®Google Scholar
• Boxer, A. L., Lang, A. E., Grossman, M., Knopman, D. S., Miller, B. L., Schneider, L. S., … Investigators, A. L. (2014). Davunetide in patients with progressive supranuclear palsy: A randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol, 13(7), 676–685.
   PubMed Web of Science ®Google Scholar
• Boxer, A. L., Yu, J. T., Golbe, L. I., Litvan, I., Lang, A. E., & Hoglinger, G. U. (2017). Advances in progressive supranuclear palsy: New diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol, 16(7), 552–563.
   PubMed Web of Science ®Google Scholar
• Collinson, S. L., Fang, S. H., Lim, M. L., Feng, L., & Ng, T. P. (2014, August). Normative data for the repeatable battery for the assessment of neuropsychological status in elderly Chinese. Arch Clin Neuropsychol, 29(5), 442–455. Epub 2014 Jun 5. PubMed PMID: 24903208.
   PubMed Web of Science ®Google Scholar
• Cotelli, M., Borroni, B., Manenti, R., Alberici, A., Calabria, M., Agosti, C., … Cappa, S. F. (2006). Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. Neuropsychology, 20(5), 558–565.
   PubMed Web of Science ®Google Scholar
• De la Torre, G. G., Suárez-Llorens, A., Caballero, F. J., Ramallo, M. A., Randolph, C., Lleó, A., … Sánchez, B. (2014). Norms and reliability for the Spanish version of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Form A. J Clin Exp Neuropsychol, 36(10), 1023–1030. Epub 2014 Nov 3. PubMed PMID: 25363544.
   PubMed Web of Science ®Google Scholar
• Duff, K., Beglinger, L., Theriault, D., Allison, J., & Paulsen, J. (2010). Cognitive deficits in Huntington’s disease on the repeatable battery for the assessment of neuropsychological status. J Clin Exp Neuropsychol, 32(3), 231–238.
   PubMed Web of Science ®Google Scholar
• Duff, K., Gerstenecker, A., & Litvan, I. (2013). Functional impairment in progressive supranuclear palsy. Neurology, 80(4), 380–384.
   PubMed Web of Science ®Google Scholar
• Duff, K., Humphreys Clark, J. D., O’Bryant, S. E., Mold, J. W., Schiffer, R. B., & Sutker, P. B. (2008). Utility of the RBANS in detecting cognitive impairment associated with Alzheimer’s disease: Sensitivity, specificity, and positive and negative predictive powers. Arch Clin Neuropsychol, 23(5), 603–612.
   PubMed Web of Science ®Google Scholar
• Dutt, S., Binney, R. J., Heuer, H. W., Luong, P., Attygalle, S., & Bhatt, P.; investigators, A. L. (2016). Progression of brain atrophy in PSP and CBS over 6 months and 1 year. Neurology, 87(19), 2016–2025.
   PubMed Web of Science ®Google Scholar
• Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12(3), 189–198.
   PubMed Web of Science ®Google Scholar
• Gerstenecker, A., Duff, K., Mast, B., Litvan, I., & Group, E.-P. S. (2013). Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Res, 210(3), 1205–1210.
   PubMed Web of Science ®Google Scholar
• Gerstenecker, A., Mast, B., Duff, K., Ferman, T. J., Litvan, I., & Group, E.-P. S. (2013). Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol, 28(2), 104–113.
   PubMed Web of Science ®Google Scholar
• Golbe, L. I., & Ohman-Strickland, P. A. (2007). A clinical rating scale for progressive supranuclear palsy. Brain, 130(Pt 6), 1552–1565.
   PubMedGoogle Scholar
• Goldbecker, A., Weissenborn, K., Hamidi Shahrezaei, G., Afshar, K., Rümke, S., Barg-Hock, H., … Tryc, A. B. (2013, October). Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut, 62(10), 1497–1504. Epub 2013 Jan 7. PubMed PMID: 23297006.
   PubMed Web of Science ®Google Scholar
• Grafman, J., Weingartner, H., Newhouse, P. A., Thompson, K., Lalonde, F., Litvan, I., … Sunderland, T. (1990). Implicit learning in patients with Alzheimer’s disease. Pharmacopsychiatry, 23(2), 94–101.
   PubMed Web of Science ®Google Scholar
• Hoglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., … Movement disorder society-endorsed, P. S. P. S. G. (2017). Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord, 32(6), 853–864.
   PubMed Web of Science ®Google Scholar
• Hoglinger, G. U., Schope, J., Stamelou, M., Kassubek, J., Del Ser, T., Boxer, A. L., … Movement disorder society-endorsed, P. S. P. S. G. (2017). Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials. Mov Disord, 32(6), 842–852.
   PubMed Web of Science ®Google Scholar
• Liogier d’Ardhuy, X., Edgin, J. O., Bouis, C., de Sola, S., Goeldner, C., Kishnani, P., … Khwaja, O. (2015, November 18). Assessment of cognitive scales to examine memory, executive function and language in individuals with down syndrome: Implications of a 6-month observational study. Front Behav Neurosci, 9, 300. eCollection 2015. PubMed PMID: 26635554; PubMed Central PMCID: PMC4650711.
   PubMed Web of Science ®Google Scholar
• Litvan, I. (1994). Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl, 42, 69–78.
   PubMedGoogle Scholar
• Litvan, I., & Hutton, M. (1998). Clinical and genetic aspects of progressive supranuclear palsy. J Geriatr Psychiatry Neurol, 11(2), 107–114.
   PubMed Web of Science ®Google Scholar
• Paviour, D. C., Winterburn, D., Simmonds, S., Burgess, G., Wilkinson, L., Fox, N. C., … Jahanshahi, M. (2005). Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase, 11(4), 274–282.
   PubMed Web of Science ®Google Scholar
• Randolph, C. (1998). Repeatable battery for the assessment of neuropsychological status. San Antonio, TX: The Psychological Coporation.
   Google Scholar
• Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol, 20(3), 310–319.
   PubMed Web of Science ®Google Scholar
• Rojas, J. C., Bang, J., Lobach, I. V., Tsai, R. M., Rabinovici, G. D., Miller, B. L., … Investigators, A. L. (2018). CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. Neurology, 90(4), e273–e281.
   PubMed Web of Science ®Google Scholar
• Schwab, R. S., & England, A. C. (1969). Projection technique for evaluating surgery in Parkinson’s disease. In F. J. Gillingham & M. C. Donaldson (Eds.), Third symposium on parkinson’s disease (pp. 152–157). Edinburgh: Livingstone.
   Google Scholar
• Soliveri, P., Monza, D., Paridi, D., Carella, F., Genitrini, S., Testa, D., & Girotti, F. (2000). Neuropsychological follow up in patients with Parkinson’s disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 69(3), 313–318.
   PubMed Web of Science ®Google Scholar
• Yamashima, T., Yoshida, M., Kumahashi, K., Matsui, M., Koshino, Y., Higashima, M., … Matsushita, M. (2002, June). The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status)]. No To Shinkei, 54(6), 463–471. Japanese. PubMed PMID: 12166095.
   PubMedGoogle Scholar
• Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M. B., & Leirer, V. O. (1983). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17, 37–49.
   Web of Science ®Google Scholar